Analyst Ratings for Clovis Oncology (CLVS) [Neutrals]
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.9 / 10
Percentile Rank: 38%
Rating Score: 3.9 / 10
Percentile Rank: 38%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/19/2019 | Evercore ISI | Joshua Schimmer | Downgrade | In Line (Outperform) |
8.00 (N/A) |
7.06 (0.08) |
-98.87% | Details |
| 8/2/2019 | Guggenheim | Michael Schmidt | Downgrade | Neutral (Buy) |
N/A (N/A) |
10.55 (0.08) |
-99.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
